{"id":9639,"date":"2017-06-13T14:39:15","date_gmt":"2017-06-13T14:39:15","guid":{"rendered":"http:\/\/www.fetaldna.it\/metodologia-inipt\/"},"modified":"2022-03-04T09:38:55","modified_gmt":"2022-03-04T09:38:55","slug":"nipt-metodologia-inipt","status":"publish","type":"page","link":"https:\/\/www.fetaldna.it\/en\/nipt-metodologia-inipt\/","title":{"rendered":"FETALDNA iNIPT&#x2122;"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row full_width=&#8221;stretch_row&#8221; content_placement=&#8221;middle&#8221; css=&#8221;.vc_custom_1642093547936{padding-top: 100px !important;padding-bottom: 50px !important;background-image: url(https:\/\/www.fetaldna.it\/wp-content\/uploads\/2022\/01\/Header_inipt.png?id=13439) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}&#8221;][vc_column css=&#8221;.vc_custom_1642010227194{padding-top: 100px !important;padding-bottom: 100px !important;}&#8221;][\/vc_column][\/vc_row][vc_row 0=&#8221;&#8221; softing_row_prepad=&#8221;ptb-30&#8243;][vc_column 0=&#8221;&#8221;][vc_custom_heading text=&#8221;From NIPT to iNIPT: innovation in prenatal screening&#8221; font_container=&#8221;tag:h2|text_align:center&#8221; use_theme_fonts=&#8221;yes&#8221;][vc_column_text]<\/p>\n<h3 style=\"text-align: center;\">Beyond Massive Parallel Sequencing, Massive Parallel and Digital Sequencing is now the state-of-the-art.<\/h3>\n<p>[\/vc_column_text][vc_column_text css=&#8221;.vc_custom_1646347078622{padding-top: 3% !important;}&#8221;]The technology that makes FetalDNA unique in the fetal DNA test landscape is iNIPT<sup>TM<\/sup>, developed within the Genetics Laboratory of the Altamedica Healtcare Center in Rome.<\/p>\n<p>It is an<strong> integrated platform for the latest generation of genetic sequencing<\/strong>, which involves the synergistic use of technologies of massive DNA sequencing (Next Generation Sequencing) and Digital PCR (Polymerase Chain Reaction).<\/p>\n<p>While the already known method of parallel massive sequencing allows the analysis of the entire genome, Digital PCR represents the possibility of investigating genetic mutations and anomalies with a sensitivity and reliability never achieved before.<\/p>\n<p>In addition, the use of proprietary bioinformatics analysis provides <strong>really high reliability in results<\/strong>.[\/vc_column_text][\/vc_column][\/vc_row][vc_row 0=&#8221;&#8221;][vc_column 0=&#8221;&#8221;][vc_column_text]<\/p>\n<h3 style=\"text-align: center;\">Superiority of iNIPT<sup>TM<\/sup><br \/>\nover traditional NIPT: scientific evidence<\/h3>\n<p>[\/vc_column_text][vc_column_text css=&#8221;.vc_custom_1646347209461{padding-top: 3% !important;}&#8221;]It should be noted that, beyond the excessive success rates declared by the traditional NIPT tests on the market for years, their real validity can only be established through Amniocentesis \/ CVS.<\/p>\n<p>During the period from September 2014 to September 2017, the Altamedica Center in Rome recorded <strong>15,173<\/strong> invasive prenatal procedures related to <strong>Amniocentesis<\/strong> and <strong>CVS<\/strong>.<\/p>\n<p>In this large group, we selected<strong> 385 pregnancies<\/strong> in which a NIPT test reported a doubt in a chromosomal or subchromosomal abnormality or ultrasound scans revealed the suspicion of a chromosomal or genetic abnormality even if the NIPT test was negative for chromosomal pathology.<\/p>\n<p>This preclinical study showed that:[\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=&#8221;stretch_row&#8221; equal_height=&#8221;yes&#8221; content_placement=&#8221;middle&#8221; softing_row_prepad=&#8221;ptb-30&#8243; css=&#8221;.vc_custom_1642091380162{background-color: #f2483e !important;}&#8221;][vc_column][vc_row_inner content_placement=&#8221;middle&#8221;][vc_column_inner width=&#8221;1\/2&#8243; css=&#8221;.vc_custom_1642091516293{border-top-width: 2px !important;border-right-width: 2px !important;border-bottom-width: 2px !important;border-left-width: 2px !important;padding-top: 3% !important;padding-right: 3% !important;padding-bottom: 3% !important;padding-left: 3% !important;background-color: #ffffff !important;border-left-color: #f2483e !important;border-left-style: solid !important;border-right-color: #f2483e !important;border-right-style: solid !important;border-top-color: #f2483e !important;border-top-style: solid !important;border-bottom-color: #f2483e !important;border-bottom-style: solid !important;border-radius: 5px !important;}&#8221;][vc_column_text]The <strong>first group<\/strong> reported <strong>197 women<\/strong> with a <strong>positive NIPT test<\/strong> who underwent an invasive prenatal examination (amniocentesis or CVS) to confirm the diagnosis (TAB 1).[\/vc_column_text][vc_single_image image=&#8221;11163&#8243; img_size=&#8221;large&#8221; alignment=&#8221;center&#8221;][vc_column_text]False positives range from 10% to 84% (for microdeletions), 9.5% for T21 and 36.8% for T18, <strong>dPCR reduces to zero the false positive<\/strong> rate for fetal abnormalities of chromosome 18 and 21.<\/p>\n<p><strong>Altamedica team performed the FetalDNA test preclinically | iNIPT&#x2122; technology to validate its accuracy compared to traditional NIPT.<\/strong>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=&#8221;1\/2&#8243; css=&#8221;.vc_custom_1642091525232{border-top-width: 2px !important;border-right-width: 2px !important;border-bottom-width: 2px !important;border-left-width: 2px !important;padding-top: 3% !important;padding-right: 3% !important;padding-bottom: 3% !important;padding-left: 3% !important;background-color: #ffffff !important;border-left-color: #f2483e !important;border-left-style: solid !important;border-right-color: #f2483e !important;border-right-style: solid !important;border-top-color: #f2483e !important;border-top-style: solid !important;border-bottom-color: #f2483e !important;border-bottom-style: solid !important;border-radius: 5px !important;}&#8221;][vc_column_text]The <strong>second group<\/strong> included <strong>188\u00a0 women<\/strong> who underwent invasive prenatal diagnosis after a negative NIPT test but there was an ultrasound suspicion of fetal chromosomal pathology\u00a0(<a href=\"https:\/\/www.fetaldna.it\/metodologia-inipt\/#tab1\"><strong>TAB 2<\/strong><\/a>).<\/p>\n<p>[\/vc_column_text][vc_single_image image=&#8221;11168&#8243; img_size=&#8221;large&#8221; alignment=&#8221;center&#8221;][vc_column_text]<\/p>\n<p style=\"text-align: left;\">False negatives range from 5% to 10%, <strong>dPCR reduces the false negative rate<\/strong> for fetal abnormalities of chromosome 18 and 21 to zero.<\/p>\n<p><strong>The Altamedica team executed the FetalDNA test | iNIPT &#x2122; technology\u00a0preclinically in order to validate its accuracy compared to traditional NIPT.<\/strong>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row el_id=&#8221;tab2&#8243;][vc_column][vc_column_text]* <i>Ultrasound Obstet Gynecol. 2017 Jun; 49(6):815-816. doi: 10.1002\/uog.17483.\u00a0<\/i><i>ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing<\/i><i> on screening policies and prenatal ultrasound practice.\u00a0<\/i><i>S<\/i><i>alomon LJ, Alfirevic Z, Audibert F, Kagan KO, Paladini D, Yeo G, <\/i><i>Raine-Fenning N; ISUOG Clinical Standards Committee.\u00a0<\/i>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row full_width=&#8221;stretch_row&#8221; content_placement=&#8221;middle&#8221; css=&#8221;.vc_custom_1642093547936{padding-top: 100px !important;padding-bottom: 50px !important;background-image: url(https:\/\/www.fetaldna.it\/wp-content\/uploads\/2022\/01\/Header_inipt.png?id=13439) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}&#8221;][vc_column css=&#8221;.vc_custom_1642010227194{padding-top: 100px !important;padding-bottom: 100px !important;}&#8221;][\/vc_column][\/vc_row][vc_row 0=&#8221;&#8221; softing_row_prepad=&#8221;ptb-30&#8243;][vc_column 0=&#8221;&#8221;][vc_custom_heading text=&#8221;From NIPT to iNIPT: innovation in prenatal screening&#8221; font_container=&#8221;tag:h2|text_align:center&#8221; use_theme_fonts=&#8221;yes&#8221;][vc_column_text] Beyond Massive Parallel Sequencing, Massive Parallel and Digital Sequencing is now the state-of-the-art. [\/vc_column_text][vc_column_text css=&#8221;.vc_custom_1646347078622{padding-top: 3% !important;}&#8221;]The technology that makes FetalDNA&#8230;<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"custom-page.php","meta":{"footnotes":""},"class_list":["post-9639","page","type-page","status-publish","hentry"," c-blog-1-item  nt-post-class"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NIPT - metodologia innovativa iNIPT per screening prenatale - FetalDNA<\/title>\n<meta name=\"description\" content=\"La metodologia iNIPT supera la NIPT tradizionale, integrando il Sequenziamento massivo del DNA (NGS) con la Digital PCR. Brevetto Altamedica\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fetaldna.it\/en\/nipt-metodologia-inipt\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NIPT - metodologia innovativa iNIPT per screening prenatale - FetalDNA\" \/>\n<meta property=\"og:description\" content=\"La metodologia iNIPT supera la NIPT tradizionale, integrando il Sequenziamento massivo del DNA (NGS) con la Digital PCR. Brevetto Altamedica\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fetaldna.it\/en\/nipt-metodologia-inipt\/\" \/>\n<meta property=\"og:site_name\" content=\"FetalDNA\" \/>\n<meta property=\"article:modified_time\" content=\"2022-03-04T09:38:55+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.fetaldna.it\\\/en\\\/nipt-metodologia-inipt\\\/\",\"url\":\"https:\\\/\\\/www.fetaldna.it\\\/en\\\/nipt-metodologia-inipt\\\/\",\"name\":\"NIPT - metodologia innovativa iNIPT per screening prenatale - FetalDNA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.fetaldna.it\\\/#website\"},\"datePublished\":\"2017-06-13T14:39:15+00:00\",\"dateModified\":\"2022-03-04T09:38:55+00:00\",\"description\":\"La metodologia iNIPT supera la NIPT tradizionale, integrando il Sequenziamento massivo del DNA (NGS) con la Digital PCR. Brevetto Altamedica\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.fetaldna.it\\\/en\\\/nipt-metodologia-inipt\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.fetaldna.it\\\/en\\\/nipt-metodologia-inipt\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.fetaldna.it\\\/en\\\/nipt-metodologia-inipt\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.fetaldna.it\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FETALDNA iNIPT&#x2122;\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.fetaldna.it\\\/#website\",\"url\":\"https:\\\/\\\/www.fetaldna.it\\\/\",\"name\":\"FetalDNA | Il test prenatale su DNA fetale\",\"description\":\"Il test prenatale di ultima generazione\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.fetaldna.it\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NIPT - metodologia innovativa iNIPT per screening prenatale - FetalDNA","description":"La metodologia iNIPT supera la NIPT tradizionale, integrando il Sequenziamento massivo del DNA (NGS) con la Digital PCR. Brevetto Altamedica","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fetaldna.it\/en\/nipt-metodologia-inipt\/","og_locale":"en_US","og_type":"article","og_title":"NIPT - metodologia innovativa iNIPT per screening prenatale - FetalDNA","og_description":"La metodologia iNIPT supera la NIPT tradizionale, integrando il Sequenziamento massivo del DNA (NGS) con la Digital PCR. Brevetto Altamedica","og_url":"https:\/\/www.fetaldna.it\/en\/nipt-metodologia-inipt\/","og_site_name":"FetalDNA","article_modified_time":"2022-03-04T09:38:55+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.fetaldna.it\/en\/nipt-metodologia-inipt\/","url":"https:\/\/www.fetaldna.it\/en\/nipt-metodologia-inipt\/","name":"NIPT - metodologia innovativa iNIPT per screening prenatale - FetalDNA","isPartOf":{"@id":"https:\/\/www.fetaldna.it\/#website"},"datePublished":"2017-06-13T14:39:15+00:00","dateModified":"2022-03-04T09:38:55+00:00","description":"La metodologia iNIPT supera la NIPT tradizionale, integrando il Sequenziamento massivo del DNA (NGS) con la Digital PCR. Brevetto Altamedica","breadcrumb":{"@id":"https:\/\/www.fetaldna.it\/en\/nipt-metodologia-inipt\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fetaldna.it\/en\/nipt-metodologia-inipt\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.fetaldna.it\/en\/nipt-metodologia-inipt\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fetaldna.it\/en\/"},{"@type":"ListItem","position":2,"name":"FETALDNA iNIPT&#x2122;"}]},{"@type":"WebSite","@id":"https:\/\/www.fetaldna.it\/#website","url":"https:\/\/www.fetaldna.it\/","name":"FetalDNA | Il test prenatale su DNA fetale","description":"Il test prenatale di ultima generazione","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fetaldna.it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.fetaldna.it\/en\/wp-json\/wp\/v2\/pages\/9639","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fetaldna.it\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.fetaldna.it\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.fetaldna.it\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fetaldna.it\/en\/wp-json\/wp\/v2\/comments?post=9639"}],"version-history":[{"count":5,"href":"https:\/\/www.fetaldna.it\/en\/wp-json\/wp\/v2\/pages\/9639\/revisions"}],"predecessor-version":[{"id":14019,"href":"https:\/\/www.fetaldna.it\/en\/wp-json\/wp\/v2\/pages\/9639\/revisions\/14019"}],"wp:attachment":[{"href":"https:\/\/www.fetaldna.it\/en\/wp-json\/wp\/v2\/media?parent=9639"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}